It is a sedation-free, lower-risk, cost-effective alternative to traditional endoscopy. The EvoEndo® System introduces a sedation-free, lower-risk, cost-effective alternative to traditional endoscopy. We incorporate a single-use, ultra-slim, flexible scope with four-way steering, a portable controller with advanced image quality, and a virtual reality-based system for patient distraction. The newl
y released 2025 ACG Guidelines for Eosinophilic Esophagitis (EoE) mark a significant step toward safer, more accessible, and patient-centered care—particularly for pediatric populations. EvoEndo applauds ACG for its updated guidance, and we are proud that our technology aligns with these evolving standards of care. FDA Cleared Indications for Use:
The EvoEndo Model LE Gastroscope is intended for the visualization of the upper digestive tract in adults and pediatric patients, specifically for the observation, diagnosis, and endoscopic treatment of the esophagus, stomach, and duodenal bulb. The gastroscope is a sterile single-use device and can be inserted orally or transnasally. The 110 cm gastroscope is intended to be used in adult and pediatric populations. The 85 cm gastroscope is intended to be used in the pediatric population. The EvoEndo Controller is intended for use with an EvoEndo Endoscope for endoscopic diagnosis, treatment, and video observation.
